Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout

被引:0
作者
Peter E Lipsky
Leonard H Calabrese
Arthur Kavanaugh
John S Sundy
David Wright
Marsha Wolfson
Michael A Becker
机构
[1] Cleveland Clinic Foundation,Lerner College of Medicine
[2] University of California San Diego,Rheumatology Section
[3] Duke University Medical Center,undefined
[4] Savient Pharmaceuticals Inc,undefined
[5] Formerly of Savient Pharmaceuticals Inc,undefined
[6] University of Chicago,undefined
来源
Arthritis Research & Therapy | / 16卷
关键词
Uric Acid; Serum Uric Acid; Rasburicase; Pegloticase; PEGylated Protein;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 94 条
[11]  
Perez-Ruiz F(2006)Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase Arthritis Res Ther 8 R12-244
[12]  
Veronese FM(2007)Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes J Control Release 119 236-62
[13]  
Mero A(2008)Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes Int J Pharm 354 56-2279
[14]  
Sundy JS(2009)Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles Pharm Res 26 2270-39
[15]  
Baraf HS(1984)Polyethylene glycol reactive antibodies in man: titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo, and in healthy blood donors Int Arch Allergy Appl Immunol 74 36-245
[16]  
Yood RA(2011)A double antigen bridging immunogenicity ELISA for the detection of antibodies to polyethylene glycol polymers J Pharmacol Toxicol Methods 64 238-955
[17]  
Edwards NL(2010)Systematic review and meta analysis: polyethylene glycol in adults with non-organic constipation Int J Clin Pract 64 944-2575
[18]  
Gutierrez-Urena SR(2010)Delivery of therapeutic proteins J Pharm Sci 99 2557-1957
[19]  
Treadwell EL(2009)Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged Cancer Immunol Immunother 58 1949-undefined
[20]  
Vázquez-Mellado J(undefined)undefined undefined undefined undefined-undefined